MagAssist
Suzhou
About MagAssist
Suzhou Xinqing Medical Technology Co., Ltd. was founded in 2017 by Dr. Xu Bozhen, a special expert of the National Youth Thousand People Program and a special professor of Suzhou University. He is a high-tech enterprise with the main goal of developing the world's leading in vitro short-term ventricular assist device (in vitro artificial heart). . The core members of the company's entrepreneurial team are the world's top artificial heart engineering technology experts. With years of experience in overseas artificial heart research and development and productization, the company has developed a domestically produced artificial heart with independent intellectual property rights.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $93.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2021)
- Website: magassist.com.cn
- Phone: 0512-65825859
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/magassist-49902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.